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Abstract
Gulf War Illness (GWI), which affects at least one fourth of the 700,000 veterans deployed
to the Gulf War (GW), is characterized by persistent and heterogeneous symptoms, includ-
ing pain, fatigue and cognitive problems. As a consequence, this illness remains difficult to
diagnose. Rodent models have been shown to exhibit different symptomatic features of
GWI following exposure to particular GW agents (e.g. pyridostigmine bromide, permethrin
and DEET) and/or stress. Preclinical analyses have shown the activation of microglia and
astroglia as a pathological hallmark in these mouse and rat models. Although much has
been learned in recent years from these different rodent models and independent clinical
studies, characterization studies to identify overlapping features of GWI in animals and
humans have been missing. Thus, we aimed to identify biomarkers that co-occur in the
plasma of rodent models of GWI and human GWI patients. We observed increases of multi-
ple phospholipid (PL) species across all studied cohorts. Furthermore, these data sug-
gested dysfunction within ether and docosahexaenoic acid and arachidonic acid containing
PL species in relation to GWI. As these PL species play a role in inflammatory processes,
these findings suggest a possible role for inflammatory imbalance in GWI. Overall, we show
that the peripheral lipid disturbances are present both in human GWI patients and in the pre-
clinical rodent models of GWI, highlighting the importance of lipidomics as a potential plat-
form for further biomarker discovery and supporting the value of GW agent exposed models
of GWI.
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Introduction
Gulf War Illness (GWI) is a chronic multisymptom illness, which affects approximately one
fourth of the 700,000 US veterans, who were deployed to the 1990–91 Persian Gulf War (GW)
[1–7]. Veterans with GWI experience chronic health symptoms such as fatigue, muscle and
joint pain and gastrointestinal problems [8]. Among the central nervous system (CNS) based
symptoms, memory problems are among the most commonly reported complaints [1,2,5,8–
13]. The multiplicity and heterogeneity of symptoms observed in GW veterans is unique to the
1990–91 deployment, with no identical illness being reported in any other military campaign,
indicating that GWI etiology cannot solely be attributed to combat-related stress [2,10,14–17].
Twenty-five years later, GW veterans are still struggling with this chronic illness, which
remains difficult to diagnose due to a lack of objective diagnostic tests. Currently, clinical diag-
nosis is most commonly made by self-report of health symptoms using the Fukuda Center for
Disease Control (CDC) or the Kansas criteria [2,5,8,18]. Consequently, many GW veterans
report symptoms consistent with GWI but have not received a formal diagnosis of their condi-
tion. Blood based biomarkers of GWI are needed to assist clinicians with providing an objec-
tive diagnosis of GWI and for developing targeted treatment strategies.
After performing a comprehensive review of clinical and animal research studies conducted
to identify the causes of GWI, the Research Advisory Committee (RAC) on GW Veterans’ Ill-
ness concluded that the key contributors to the etiology of GWI included combined war-time
exposure of the prophylactic anti-nerve gas pill pyridostigmine bromide (PB) and pesticides
which were also used prophylactically to protect against insect-borne diseases [1,7,8]. The
many pesticides used during the GW included irreversible and reversible acetylcholinesterase
inhibitors (AChEi) including organophosphate (OP) and carbamate pesticides [1,8]. Other
commonly used pesticides included pyrethroids, such as permethrin (PER), the insect repel-
lant N, N-diethyl-m-toluamide (DEET) and organophosphates such as diisopropyl fluoropho-
sphate (DFP) [1,14–16,19–23]. Organophosphate exposure from low-level sarin nerve agent
exposure also occurred in many GW veterans and is modeled in animal studies with the sarin
surrogate diisopropyl fluorophosphate (DFP). Results of these studies showed a chronic neu-
roinflammatory phenotype as a result of this sarin-surrogate exposure, particularly when
administered in conjunction with a physical stressor [24].
The complex clinical presentation of GWI suggests that various biological and metabolic
processes might be altered in GW veterans. For example, impaired immune responses have
been observed in veterans with GWI [8]. Veterans with GWI showed altered expression of
pro-and anti-inflammatory cytokines on their peripheral immune cell. Additionally, immune
system irregularities were especially pronounced in GWI patients compared to controls during
exercise challenge, such as increased IL-6, IL-10, and TNF-α levels, as well as a Th1/Th17
immune polarization [25–30].
Phospholipids (PL) are critical components of most cellular membranes, including mito-
chondrial membranes, and their metabolism generates bioactive lipids that can modulate
inflammatory pathways [31]. In particular, phosphatidylcholine (PC) and phosphatidyletha-
nolamine (PE) serve as a reservoir for ω-3 docosahexaenoic acid (DHA) and ω-6 arachidonic
acid (AA), metabolism of which generates bioactive lipid that can alter the immune/inflamma-
tory responses in both the central and the peripheral nervous system. For instance, DHA is a
precursor of the anti-inflammatory mediators, resolvins and neuroprotectins, whereas AA is a
precursor of some pro-inflammatory lipid mediators, such as prostaglandins and leukotrienes
[32,33]. Preclinical studies have shown that exposure to GW agents can affect the brain phos-
phocholine levels [34], which is a metabolite of PC required for the endogenous synthesis of
acetylcholine (ACh) [35]. In addition, mitochondrial dysfunction is thought to underlie the
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clinical features of GWI [36–38]. Furthermore, mitochondria also contain substantial amounts
of PL, of which 75% are PC and PE and 10% are phosphatidylinositol (PI) [39].
We previously established several mouse models using exposure to different combinations
of these GW agents to investigate the complex underlying GWI pathology, which presumably
involves multiple physiological and biochemical mechanisms. We showed that PB+PER co-
administration in a CD1 mouse model daily for 10 consecutive days led to observed anxiety 30
days post exposure and delayed cognitive impairment 5 months post exposure [16]. Addition-
ally, at 5 months post exposure, astrogliosis was observed in exposed mice. Proteomic analyses
revealed alteration of multiple biological systems, such as endocrine function, immune and
inflammatory pathways, as well as disturbances in lipid metabolism. For example, the fatty
acid-binding protein 3 (FABP3) was reduced in exposed animals [16]. This protein plays an
important role in the uptake of AA in the brain [40]. We subsequently translated the PB+PER
exposure model to the more commonly used C57BL6/J strain of mice, again showing cognitive
deficits associated with increased astrogliosis, as well as reduction of synaptophysin staining in
the hippocampi and cerebral cortices at 5 months post exposure [41]. Since the neurobeha-
vioral features we observed in our mouse model correlate with symptoms that are relevant to
the clinical presentation of GWI, it is possible that identified pathologies in these animals are
also present in human GWI patients [5,9,42]. We have also reported elevated ether and diacyl
PC species in the brains of these mice [34].
The insect repellant, DEET has also been named one of the key contributors to GWI, and it
has been suggested that stress modulates GWI symptoms in humans [6,42,43]. Addressing
these additional exposures, Shetty and colleagues developed and characterized a rat model of
GWI using a PB+PER+DEET exposure paradigm, along with 5 min of restraint stress to
mimic war related stress [14,44,45]. Their rat GWI model showed memory and mood dysfunc-
tion evident by deficits in spatial memory and increased depressive behavior [44]. They also
observed some loss of glutamatergic neurons, activated microglia, hypertrophy of astrocytes,
reduced neurogenesis [44] and loss of certain subpopulations of gamma-amino butyric acid
(GABA)-ergic interneurons in the hippocampus [46].
These mouse and rat studies have been critical for advancing our understanding of the differ-
ent facets of GWI pathology and for characterizing the underlying biological features. However,
translational studies between different animal models and human patients are currently lacking.
Furthermore, there remains a need for identifying novel biomarkers, which can assist with diag-
nosing GWI and may also help link preclinical and clinical studies aimed at developing thera-
pies. We deliberately chose two different models of GWI to capture the diversity of exposure
paradigms experienced by the soldiers during the Gulf War. Taking into account the role of PL
disturbances detected in preclinical rodent models of GWI and the need for translational valida-
tion studies, we hypothesize that exposure to GW chemicals in rodents may correspond with
changes in plasma PL profiles. We also propose that overlapping changes in PL profiles between
diverse rodent models of GWI may capture aspects of PL abnormalities in GW veterans with
this multisymptom illness, which could aid with diagnosing this illness in the future.
We performed lipidomic analysis in the plasma of two different rodent models described
above, which we then compared to results from a cohort of GW veterans with and without
GWI.
Materials & methods
Animals
GWI mouse model. All mouse experiments were conducted at the Roskamp Institute in
Sarasota, Florida and were approved by the Roskamp Institute’s Institutional Animal Care and
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Use Committee and conducted in accordance with the Office of Laboratory Animal Welfare
and the Association for the Assessment and Accreditation of Laboratory Animal Care. Mice
were purchased from Jackson Laboratories (Bar Harbor, Maine) and each mouse was individ-
ually housed in a controlled environment (regulated 14-h day/10-h night cycle) and main-
tained on a standard diet. We used a standard diet (ENVIGO, IN) that contains a standard
mixture of macronutrients (protein (19.1%), fat (6.5%), carbohydrate (47%), crude fiber
(2.7%), neutral detergent fiber (12.3%), ash (5.1%)) and fatty acids (both omega-6 and omega-
3, SFA (0.8%), MUFA (1.1%) and PUFA (2.9%)). The diet contained 2.6% linoleic acid and
0.3% alpha linolenic acid and contained less than 0.01% arachidonic acid (AA), docosahexae-
noic acid (DHA) and eicosapentaenoic acid (EPA).
Since control animals are on the same diet, any potential dietary issues are controlled for
in this study design. The exposure paradigm has been previously described [41,47]. Male
C57BL6/J mice (12 weeks of age) were co-administered with either a 50μl total volume of GW
agents to a final dose of 0.7 mg/kg of PB (Fisher Scientific (Hanover Park, IL)) and 200 mg/kg
of PER (Sigma Aldrich (St. Louis, MO)) in 100% dimethyl sulfoxide (DMSO) [exposed mice;
n = 4], or a 50μl volume of vehicle (100% DMSO) [sham mice; n = 4] via intraperitoneal injec-
tion (IP) injection daily, for 10 days. According to the RAND survey, PB consumption was to
commence only after the commander’s order and, as such, not all soldiers took PB throughout
the conflict. It is unclear when the orders to take PB were issued in relation to the actual battle.
The report also suggests that tablets were taken during the ground war, which only lasted days.
As our focus was co-exposure to pesticides and PB over a short-term so an acute co-exposure
to PB and PER was administered for 10 days as the basis for mouse model development [48].
The dose of 0.7mg/kg for PB was utilized based on the estimates provided by the Department
of Defense suggesting that a number of military personnel took two 30 mg tablets (60mg/75kg
per person equals about 0.8mg/kg) per day during the GW [49] and was determined to be suit-
able for administration in C57BL6 mouse strain based on our pilot work. There is no accurate
account of how much PER was used during the GW as soldiers liberally used these chemicals
where it was applied on the skin surface directly, inhaled through sprays and was embedded in
their uniforms [1]. Therefore, we used 200 mg/kg of PER in order mimic a high-level exposure,
which has shown adverse pathological outcome in previous studies [34,41,47,50–53]. The
doses of PB and PER are less than one fifth and one half of the known LD50 values in rodents,
respectively [54,55]. Six months post exposure, mice were euthanized, and plasma was col-
lected. Mice were exsanguinated via cardiac puncture using an 18-gauge wide-bore needle to
prevent hemolysis of red blood cells (RBC) during blood collection. Blood samples were col-
lected into a 1.5 ml Eppendorf tube containing 10 units of heparin and a protease inhibitor
cocktail (Roche, NJ) to a final concentration of 1 x. Samples were immediately centrifuged at
3000 x g for 5 min and the plasma was transferred to a new 1.5 ml Eppendorf tube and snap
frozen in liquid nitrogen. Plasma samples were stored at -80C until further biochemical
studies.
GWI rat model. All rat studies were conducted at the Central Texas Veterans Healthcare
System in Temple, TX. Specifically, Sprague-Dawley rats were exposed to PB, DEET, PER and
stress using previously described procedures developed by Shetty et al. [44,45]. Experiments
were in compliance with the National Institutes of Health guidelines for care and use of ani-
mals and in accordance with the animal protocol approved by the animal care and use com-
mittee of the Central Texas Veterans Health Care System, Temple TX. Three-month-old male
rats were obtained from Harlan (Indianapolis, IN) and housed for 2 weeks before being
exposed to GW agents. All rats were given food (commercial rat chow) and water ad libitum.
The rats diet (commercial rat chow; PicoLab Rodent Diet 20) contained macronutrients ((pro-
tein (20%), fat (4.5%), carbohydrate (52.9%), crude fiber (7%) and ash (7%)) as well as fatty
Plasma phospholipid profiling from GW veterans and rodent models to identify biomarkers of GWI
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acids (both omega-6/omega-3, SFA (0.93%), MUFA (0.99%) and PUFA (3.6%) normally pro-
vided in any rodent diet. The relative proportion of SFA to MUFA to PUFA was similar in the
two rodent models of GWI. Furthermore, the diet was composed of 2.19% linoleic acid and
0.26% alpha linolenic acid and contained less than 0.01% of AA, DHA and EPA.
EPA
As with mice, control and exposed rats were on the same diet, and therefore any potential
dietary issues were controlled for in this study design.
Although the ground war itself was short, the bombing continued for several weeks and it
is also suggested that solders may have taken PB throughout the conflict. In contrast to the
described mouse model above, the 4-week exposure timeframe was used in the rat model to
match a potential long-term exposure of veterans to these GW agents.
The exposure paradigm included PB (1.3 mg/kg; Sigma, St. Louis, MO), PER (200 μl, 0.13
mg/kg in 70% alcohol; Chem. Service Inc., West Chester, PA), DEET (200 μl containing 40mg/
kg in 70% alcohol; Chem. Service Inc., West Chester, PA), as well as 5 min of daily restraint
stress, via a rat restrainer for 4 weeks (exposed rats n = 5). PB was administered through oral
gavage, which corresponds to the veteran population that were given a course of twenty-one
30-mg tablets of PB every 8 hours as prophylaxis against organophosphate nerve agents [56].
This leads to a total consumption of 120mg/kg per day. For an average weight of 75 kg per
individual this would approximate 1.6 mg/kg. Rats were given 1.3mg/kg. Application of pesti-
cides in this model was limited to dermal exposure route so PER and DEET solutions were
applied to shaved skin areas located on the back of the neck. Non-exposed sham rats were
naïve controls (n = 6). Plasma samples were collected 6 months post exposure to GW agents
and stress and were sent to the Roskamp Institute investigators on dry ice.
Human subjects
Plasma samples from veterans, deployed to the 1990–1991 GW, were provided by the Boston
University and the Nova Southeastern University investigators from an established bioreposi-
tory of GW veterans, who agreed to share their blood samples from prior studies. This includes
the Boston Gulf War Illness Consortium (GWIC) and the Dynamic Modeling of GWI study
from Nova Southeastern University and the CDMRP funded study to the South Florida Veter-
ans Affairs Foundation for Research and Education, Inc. The GWI biorepository is approved
by the IRBs from Boston University, Nova Southeastern University and the Miami VAMC.
Samples from the GWI biorepository were all collected from the Boston and Miami areas
using the same standard operating procedures for phlebotomy, plasma separation and aliquot-
ing. Plasma samples were obtained from fasting subjects. All samples were stored at -80˚C and
were not previously thawed and refrozen. GW veteran participants were consented into their
respective studies using ICH GCP guidelines. The Kansas GWI criteria [5] were used to deter-
mine cases of GWI and controls. The Kansas GWI criteria require that GW veterans endorse
symptoms in at least 3 of 6 symptom domains (fatigue/sleep problems, pain, cognitive, mood
symptoms, gastrointestinal symptoms, respiratory symptoms and skin abnormalities). Con-
trols were deployed veterans from the 1991 GW who did not meet the Kansas GWI criteria.
Subjects also completed demographics and health symptom questionnaires including the Pitts-
burgh Sleep Quality Index (PSQI), Visual Analog Scale (VAS) for pain, Multi-dimensional
Fatigue Inventory (MFI-20) questionnaire, MOS Short Form 36-veteran version (SF-36V),
and Profile of Mood States (POMS). Study participants were excluded if they reported being
diagnosed with another medical condition that could explain the above mentioned symptoms
according to the Kansas GWI case definition exclusions, including veterans with a history of
prior central nervous system or major psychiatric disorders that may affect cognitive function
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(e.g., epilepsy, stroke, brain tumor, multiple sclerosis, Parkinson’s Disease, Alzheimer’s disease,
schizophrenia). Control veterans (n = 11) and veterans with GWI (n = 22) were matched for
age, gender and ethnicity. Due to low numbers in the different ethnic groups, we dichotomized
the ethnicity into Caucasian (n = 17) vs. non- Caucasian (n = 16) in order to study ethnicity
effect on PL levels in the entire cohort population independently of diagnosis. The non-Cauca-
sian group included African American (n = 8), Hispanic (n = 4), Asians (n = 2) and others
(n = 2). Baseline demographics can be found in Table 1.
Lipidomic analysis
Lipidomic analyses were performed as previously described (Emmerich et al., 2015). Briefly,
the experimenter was kept blinded to the diagnostic classification of the samples from the clin-
ical cohort and the exposure assignment of samples from the animal studies. Lipids were
extracted from plasma of human, rat and mice samples using the Folch method [57]. Synthetic
internal standards (di-14:0 fatty acid [FA] containing PC and PE, 14:0 FA containing LPE and
LPC, and di-16:0 for phosphatidylinositol [PI]) were added to plasma prior to lipid extraction.
As previously described [58], lipid extracts were resuspended in isopropanol and separation
was achieved using hydrophilic interaction chromatography (HILIC) on a 1mm x 100mm col-
umn packed with 3μm Pinnacle II silica particles (Restek Corporation, Bellefonte, PA, USA).
Two reference samples for each cohort were extracted together with the rodent and human
samples and added to each run for analytical quality control. A fifteen minute isocratic separa-
tion was performed with 70% solvent A (100% acetonitrile [ACN]) and 30% solvent B (78%
methanol, 1% formic acid, 0.6% ammonium hydroxide) at a flow rate of 55 μl/min with the
column temperature at 40˚C. Mass spectrometry (MS) was performed with a Thermo LTQ-XL
linear ion trap mass spectrometer equipped with a Surveyor HPLC pumping system and
Micro AS autosampler (Thermo-Fisher, Waltham, MA, USA). Full scan negative ion electro-
spray mass spectra were acquired from m/z 200 to 2,000 with in-source collision induced dis-
sociation (SCID), with relative energy of 15%. All spectra were obtained with a 200 msec
maximum ion time and by summing of 5 microscans. Mass spectra were summed over the
chromatographic peak for each PL class, limited to values above a threshold of 0.01% base ion
intensity, exported to Microsoft Excel (Microsoft, Redmond, WA, USA), and then analyzed
with LipidomeDB online using custom target lists for each PL class (University of Kansas,
Lawrence, KS, USA; http://129.237.137.125:8080/Lipidomics/) to identify and quantify each
PL molecular species.
The measured concentration of all molecular species identified within each PL class were
summed to generate total PC, LPC, PE, LPE and PI concentration values. Each phospholipid
Table 1. Baseline demographics of Gulf War veteran cohort.
Control GWI
N total 11 22
Age (Mean±Stdev) 48.5±7.7 48.4±6.3
Male (%) 9 (81.9%) 17 (77.3%)
Ethnicity
Caucasian 5 12
African American 3 5
Hispanic 2 2
Asian 0 2
Other 1 1
https://doi.org/10.1371/journal.pone.0176634.t001
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class of PC, LPC, PE, LPE, and PI was then separately grouped according to their degree of
unsaturation of each molecular species (SFA—saturated fatty acids, MUFA—monounsatu-
rated fatty acids, and PUFA—polyunsaturated fatty acids). Sphingomyelin was excluded from
this analysis due to its lack of PUFA-containing SM species.
Within each class, we grouped arachidonic acid (AA) containing lipid species and docosa-
hexaenoic acid (DHA) containing species of PC, LPC, PE, LPE and PI as previously described
[59]. We previously determined the identification of these species as containing AA and DHA
based on MS/MS analyses [60]. Ether PC (ePC), ePE, eLPC and eLPE were grouped separately,
as these lipids contain ether linkage at the SN1 position.
Statistical analyses
Data were checked for normal distribution histogram plots and skewness/kurtosis measures.
Statistical analyses were then performed as we have previously described [52,58]. Principal
Component Analysis (PCA) was used to minimize multi-colinearity and achieve dimension
reduction, as used routinely for the evaluation of lipidomic data. First, the Kaiser-Mayer-Olkin
(KMO) and Bartlett’s test for Sphericity was used to ensure sampling adequacy for PCA. Sam-
pling adequacy as determined by a KMO value of> 0.6 and Bartlett p value < 0.05 were fur-
ther investigated. Variables with eigenvalues of1 were retained, PCA was used for extracting
components, and varimax with Kaiser normalization was used for rotation to simplify and
clarify the data structure. In order to perform mixed linear modeling (MLM) regression analy-
sis on each component (the outcome measure), the Anderson-Rubin method was used for
exporting uncorrelated scores while adjusting for random (mice) and fixed (injury, time and
replication) factors. Following data analysis using MLM, Fisher’s least significant difference
(LSD) correction and the Benjamini–Hochberg procedure (B-H) were used for multiple-test
correction and control of false discovery rate (FDR) for all comparisons (total lipids, ether lip-
ids, DHA and AA). All data were analyzed using SPSS version 22.0.0 (IBM Corporation,
Armonk, NY). B-H (α = 0.05) was calculated using JMP 11 (SAS, Cary, NC
Results
Our aim was to first establish a plasma PL profile that could distinguish veterans with GWI
from deployed controls. We examined changes in total PL levels, (PC, PE, PI, LPC and LPE),
as well as the degree of unsaturation of PL class, ether content and ω-3 and ω-6 fatty acid (FA)
composition. We then investigated the association of individual PL molecular species with the
diagnosis of GWI. Finally, we examined these species in rodent models of GWI in order to be
able to validate these preclinical models.
Results of principal component analysis can be found in the S1–S3 Tables. Data were nor-
mally distributed and as such are presented as means and standard error of the mean (SEM),
as well as in μM ± SEM in S4–S7 Tables.
Comparison of total phospholipid classes in GWI patients and GW
deployed controls
Our case control cohort included a total of 33 veterans who were deployed to the GW region
during 1990–1991; 11 were classified as controls and 22 veterans were diagnosed with GWI. In
comparing baseline characteristics, control and GWI veterans were similar for gender, ethnic-
ity and age (see Table 1). In order to determine if gender, age and ethnicity could potentially
be confounding factors on the relationship between GWI and PL, we examined their influence
on PL levels in the entire cohorts (combined controls and GWI). A gender effect was only
observed for total PE (p = 0.004) levels. There was no significant influence of ethnicity for any
Plasma phospholipid profiling from GW veterans and rodent models to identify biomarkers of GWI
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of the PL classes. There was a significant correlation of age with LPC (r = 0.49; p<0.001) and
PI (r = 0.27; p = 0.005).
We investigated changes in total PL levels for GWI cases compared to controls, presented
as a percentage of control and shown in Fig 1 (Fig 1). For all subsequent analyses, we used gen-
der as a covariate for all analyses pertaining to PE and age as a covariate for PI and LPC in
order adjust for their potential confounding effects on relevant PL class. There were no signifi-
cant differences for total PC, PE, LPE and PI between the two comparison groups (p>0.05).
However, for total LPC post-hoc analysis revealed a significant increase of 15% for GWI
patients versus controls (p = 0.020).
Analysis of the degree of unsaturation of PL classes in human subjects
It has been shown that the brain can synthesize SFA and MUFA, however most essential
PUFA are acquired through the periphery due to the low capacity of the brain to synthesize
these de novo [61]. In order to investigate if GWI diagnosis influences unsaturation status of
different PL classes, we examined SFA, MUFA and PUFA containing PL in human subjects.
Fig 2 (Fig 2) shows SFA, MUFA and PUFA containing species of PC, LPC, PE, LPE and PI in
GWI subjects as a percentage of controls. For PI, no SFA-containing species were found.
There were no differences between veterans with GWI and controls for the degree of unsa-
turation for PE and PI even after adjusting for potential confounding by gender and age,
respectively. However, SFA containing PC species were reduced by 22% in GWI patients com-
pared to controls (p = 0.024). No changes were seen in MUFA and PUFA containing PC spe-
cies. In addition, the LPC, SFA, MUFA, and PUFA containing species were significantly
elevated in GWI compared to controls by 16%, 15% and 23%, respectively, and remained sig-
nificant after adjusting for age (p< 0.05). For LPE, PUFA containing species showed an
increase of 50% in GWI compared to controls (p<0.001), whereas SFA and MUFA containing
LPE species did not differ between the two groups.
Examination of ether lipids in plasma of GWI cases compared to controls
Ether PL are dependent upon peroxisomes for their synthesis [62]. Therefore, we grouped
ether PL within each class. Fig 3 (Fig 3) shows levels of ether PC, LPC, PE and LPE in GWI
Fig 1. Changes in total plasma phospholipid levels in GWI subjects and controls, represented in
mean ± SEM in percentage of control. Individual molecular species for each PL class identified by LC/MS
were summed to calculate total PL levels within each class. *p < 0.05; MLM regression with post hoc analysis.
Total LPC was significantly increased in GWI subjects (brick bars) compared to GV controls (solid bars).
https://doi.org/10.1371/journal.pone.0176634.g001
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subjects compared to control. No differences were observed for ePC, eLPC and ePE between
GWI and control subjects. However, eLPE levels were increased in GWI veterans by 43% rela-
tive to controls (p<0.001).
Profiling of AA- and DHA-containing phospholipid species in GWI cases
Arachidonic acid (ω-6) and DHA (ω -3) containing fatty acids play a potential role in modu-
lating inflammatory responses. Thus, individual PL species of the different classes were
Fig 2. Degree of unsaturation of PL classes in plasma of GWI patients compared to controls,
represented in mean ± SEM in percentage of control. For PC, SFA containing PC species were decreased
in GWI patients, whereas for LPC and LPE, PUFA containing species were elevated compared to control
subjects. No differences in the degree of unsaturation were observed for LPC and PE. For PI, no SFA
containing species were identified (SFA: solid bars, MUFA: stripped bars, PUFA: brick bars). *p<0.05; MLM
regression with post hoc analysis.
https://doi.org/10.1371/journal.pone.0176634.g002
Fig 3. Ether lipid changes in plasma of GWI patients and compared to controls, represented in
mean ± SEM in percentage of control. Levels of eLPE were significantly elevated in GWI patients (brick
bars) compared to healthy GW controls (solid bars). No differences were observed for ePC, eLPC and ePE.
*p<0.05; MLM regression with post hoc analysis.
https://doi.org/10.1371/journal.pone.0176634.g003
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summed together if they had an AA containing fatty acid chain or DHA fatty acid chain
respectively.
Fig 4 (Fig 4) shows AA containing PL species of PC, LPC, PE, LPE and PI. No differences
were observed for AA containing PC, PE and PI between the two groups. Compared to con-
trols, AA species within LPC and LPE were increased by 22% (p = 0.023) and 40% respectively
(p = 0.005; for LPC the p value was adjusted for potential confounding by age) in GWI com-
pared to control subjects. For LPE, age was not detected as a cofounding factor.
Fig 5 (Fig 5) shows individual DHA containing PL species in the plasma of GWI subjects
compared to controls. There were no differences between the two groups for DHA containing
PE and PI species. However, DHA species of PC were 18% higher in GWI patients compared
to controls (p = 0.0013). Furthermore, within LPC and LPE, DHA containing species were
increased in GWI compared to controls by 42% (p = 0.001) and 91% (p<0.001), respectively
(p values for PE (gender), LPC and PI (age) were adjusted as before).
Comparison of individual molecular PL species across GWI rodent
models and a GW veteran cohort
In order to examine the value of the described rodent models, we investigated individual PL
molecular species in these previously published animal models of GWI (rat model: PB+PER
+DEET and stress exposure, mouse model: PB+PER exposure) and compared them with the
clinical findings. Total PL, degree of saturation, ether and AA and DHA content PL data for
both models can be found in S1–S4 Tables. For the comparison of individual molecular species
we included PL in our analysis that showed a >1.1 fold change in humans for all PL classes
and examined those in the rodent GWI models.
Individual molecular species of PC that were significant for at least one model or the
human subject cohort are shown in Fig 6 (Fig 6). Human GWI subjects showed significant
increases in 7 out of the 10 shown individual PC species. The highest changes were observed
Fig 4. AA containing phospholipid species in plasma of GWI patients compared to controls,
represented in mean ± SEM in percentage of control. Within GWI patients (brick bars), AA containing LPC
and LPE species were significantly elevated compared to controls. No differences were observed within PC,
PE and PI. *p<0.05; MLM regression with post hoc analysis.
https://doi.org/10.1371/journal.pone.0176634.g004
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for PC(40:6) and PC(40:7) (p<0.05).Increases ranged from 12% to 28%. Although the remain-
ing 3 species showed increased levels in GWI patients, significance was not achieved. For
C57Bl6/J mice PC species ePC(38:1), PC(36:1) and PC(38:3) were non significantly elevated in
exposed compared to controls (p>0.05). As with GWI subjects, exposed rats showed signifi-
cant increases of the above-mentioned PC species, as well as the remaining 3 species compared
to controls (p<0.05).
Individual molecular species of LPC that were significant for at least one model or the
human subject cohort are shown in Fig 7 (Fig 7). After adjusting for age, we observed signifi-
cantly increased levels for 7 out of the 9 shown molecular lipid species for the GWI patients
compared to controls. Levels increased in between the range of 19% (LPC(0–18:0)) to 42%
(LPC(22:6n3)). Although the remaining 2 LPC species (LPC(18:2n6) and LPC(20:3)) did not
reach significance, a trend (p = 0.06–0.07) for the elevation was observed. For the GWI mouse
model, statistical significance was achieved for 6 out of the 9 individual molecular LPC species,
including LPC(18:2n6) and LPC(20:4n6) (p<0.05); the remaining 3 showed an a trend
increase in the PB+PER mouse group (LPC(22:6n3), p = 0.069, LPC(0–18:0), p = 0.071, LPC
(22:5n3), p = 0.063). The rat GWI model showed a significant increase of all shown LPC spe-
cies in the exposure group (p<0.05), with percent change ranging from 44% (LPC(18:0)) to
160% (LPC(22:5n3)).
Individual molecular species of PE that were significant for at least one model or the
human subject cohort, are shown in Fig 8 (Fig 8). For human subjects, although we observed
tendencies of elevated PE levels in the GWI patient group, only two molecular species reached
significance (p<0.05, ePE(36:3) and PE(42:2)). Ether PE(36:3) was elevated by 19% and PE
(42:2) by 78%. P values were adjusted for gender effect. Within the mouse model variance was
high and no molecular species was significant (p>0.05). PE species ePE(38:0) and PE(36:2)
were non-significantly elevated.
Fig 5. DHA containing phospholipid species in plasma of GWI patients compared to controls,
represented in mean ± SEM in percentage of control. Within GWI patients (brick bars), DHA containing
PC, LPC and LPE species were significantly elevated compared to controls (solid bars). No differences were
observed within DHA containing PE and PI species. *p<0.05; MLM regression with post hoc analysis.
https://doi.org/10.1371/journal.pone.0176634.g005
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Exposed rats showed the strongest signal and significant increases of all shown PE species
in the PB+PER+DEET and stress group, except one (p>0.05; PE(42:2).
Individual molecular species of LPE that were significant for at least one model or the
human subject cohort, are shown in Fig 9 (Fig 9). For LPE, all shown individual molecular spe-
cies were significantly elevated in human GWI patients compared to control (p<0.05, LPE(0–
16:1), LPE(18:0) and LPE(20:4)), with increases between 31% for LPE(0–16:1) and 46% for
LPE(18:0). The mouse model showed 2 species, which overlapped in humans that were
Fig 6. Individual molecular species of PC are elevated in plasma from veterans with GWI, rodent model and
mouse model of GWI. A. (blue) Percentage of control ± SEM (n = 11 controls, 22 GWI) showing elevated PC species in
GWI subjects compared to controls. (green) Percentage of control ± SEM (n = 4 per group) for the PB+PER model showing
that most of these species were also elevated in exposed mice but did not reach statistical significance. (red) Percentage of
control ± SEM (n = 6 sham, n = 5 exposed rats) showing elevated PC species in GW agent exposed rats compared to
control rats. B. P values for all significant PL species in GW veterans and rodent models. *p<0.05; MLM regression with
post hoc analysis.
https://doi.org/10.1371/journal.pone.0176634.g006
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elevated as well, namely for LPE(18:0) (9%) and LPE(20:4) (20%; p<0.05), whereas the rat
model only showed a significant increase for LPE(0–16:1) by 63% (p<0.05).
Individual molecular species of PI that were significant for at least one model or the human
subject cohort, are shown in Fig 10 (Fig 10). For PI, none of the shown individual molecular
species were significantly different in human GWI patients compared to control (p>0.05). P
value was adjusted for age effect. PB+PER mice showed increased levels for two out of the five
Fig 7. Individual molecular species of LPC are elevated in plasma from veterans with GWI, rodent model and
mouse model of GWI. A. (blue) Percentage of control ± SEM (n = 11 controls, 22 GWI) showing elevated LPC
species in GWI subjects compared to controls. (green) Percentage of control ± SEM (n = 4 per group) for the PB+PER
model showing that most of these species were also elevated in exposed mice. (red) Percentage of control ± SEM
(n = 6 sham, n = 5 exposed rats) showing elevated LPC species in GW agent exposed rats compared to control rats.
B. P values for all significant PL species in GW veterans and rodent models.*p<0.05; MLM regression with post hoc
analysis.
https://doi.org/10.1371/journal.pone.0176634.g007
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Fig 8. Individual molecular species of PE are elevated in plasma from veterans with GWI, rodent model and mouse model of GWI. A.
(blue) Percentage of control ± SEM (n = 11 controls, 22 GWI) showing elevated PE species in GWI subjects compared to controls. (green)
Percentage of control ± SEM (n = 4 per group) for the PB+PER model showing that most of these species were also elevated in exposed mice but
did not reach statistical significance. (red) Percentage of control ± SEM (n = 6 sham, n = 5 exposed rats) showing elevated LPC species in GW
agent exposed rats compared to control rats. B. P values for all significant PL species in GW veterans and rodent models.*p<0.05; MLM regression
with post hoc analysis.
https://doi.org/10.1371/journal.pone.0176634.g008
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PI species, PI(38:5) and PI(40:5) (p<0.05) by 20% and 13% respectively. In correlation,
exposed rats showed in correlation a significant increase for all PI species ((PI38:4), PI(38:5),
PI(40:5) and PI (40:6), with elevations ranging from 143% to 212%.
Discussion
Shortly after returning from the 1991 conflict, a large proportion of GW veterans presented
multiple symptoms, later defined as GWI. The heterogeneous clinical presentation has made it
difficult to objectively diagnose GWI, identify underlying pathology and find effective treat-
ments for this debilitating illness. Since animal modeling allows for better control of genetic
heterogeneity and environment factors, evaluation of GW exposures in rodents therefore
allow us to identify outcomes that are directly related to GW chemical exposure. As such,
identification of overlapping changes in GWI rodent models and human patients will likely
Fig 9. Individual molecular species of LPE are elevated in plasma from veterans with GWI, rodent model and
mouse model of GWI. A. (blue) Percentage of control ± SEM (n = 11 controls, 22 GWI) showing elevated LPE species in
GWI subjects compared to controls. (green) Percentage of control ± SEM (n = 4 per group) for the PB+PER model
showing that two out of three species were also elevated in exposed mice. (c) Percentage of control ± SEM (n = 6 sham,
n = 5 exposed rats) showing elevated LPE species in GW agent exposed rats compared to control rats. B. P values for all
significant PL species in GW veterans and rodent models. *p<0.05; MLM regression with post hoc analysis.
https://doi.org/10.1371/journal.pone.0176634.g009
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facilitate development of diagnostic and therapeutic approaches that are relevant to the under-
lying pathological features of GWI. In this study, we performed PL profiling to identify areas
of overlap between the clinical patient population and GWI animal models.
As reported above, the PB+PER mouse model and the PB+PER+DEET and stress rat
model utilized in this study have been well characterized with respect to neurobehavioral
features that are similar to chronic symptoms reported by GWI patients [9,10,41,44,47].
Samples from both rodent models were collected at 6 months post exposure. This six month
waiting period after exposure of rodents to GW agents is equivalent to about 17 years after
exposure in humans [63]. This waiting period is relevant as >25 years have passed since
soldiers were exposed to these chemicals during the GW. Therefore, these experiments
evaluate an extended (chronic) time point after exposure to GW agents, which is relevant to
the current clinical condition of veterans with GWI. As such, these rodent models are ideal
Fig 10. Individual molecular species of PI are elevated in plasma from veterans, rodent model and mouse
model of GWI. A. (blue) Percentage of control ± SEM (n = 11 controls, 22 GWI) showing levels PI species in GWI
subjects compared to controls. No significance was achieved for any of these species. (green) Percentage of
control ± SEM (n = 4 per group) for the PB+PER model showing that 2 out of 5 species were elevated in exposed mice.
(red) Percentage of control ± SEM (n = 6 sham, n = 5 exposed rats) showing elevated PI species in GW agent exposed
rats compared to control rats. B. P values for all significant PL species in GW veterans and rodent models.*p<0.05;
MLM regression with post hoc analysis.
https://doi.org/10.1371/journal.pone.0176634.g010
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candidates for translational studies aimed at examining long-term changes that are relevant
to chronic features of GWI symptomatology.
Evaluation of plasma PL revealed elevated levels of total LPC in veterans with GWI com-
pared to controls. Both mouse and rat models also showed significantly higher total LPC levels
in exposed animals compared to controls. For total PC, PE and PI there were no significant
differences between the groups for humans and mouse studies. However, exposed rats showed
a strong increase in these PL classes. Because rats were exposed to stress and DEET, in addition
to PB+PER, future investigation in subtypes of exposure in relation to GWI severity and symp-
tom profiles may provide insights into possible differential response to GW agents and PL
profiles.
We also examined the degree of unsaturation of different PL classes and found a good over-
lap for LPC, with all SFA, MUFA and PUFA being elevated in GWI patients and in exposed
rodents in the GWI animal models (see S1 Table). In particular, PUFA LPC species reached sta-
tistical significance in both rodent GWI models and in human GWI patients. Yet, differences
between rodents and humans for example were found for PE. For example, no significance
was observed in humans, however mice showed lower SFA and PUFA containing PE species,
whereas rats had increased levels of saturated and unsaturated PE. These studies suggest possi-
ble differences in PL profiles in response to different combinations of GW exposures and
chronicity of illness, which warrant further investigation. As most of these PL species in plasma
are bound to various lipoproteins, differences between human and rodent lipoprotein compo-
sitions could influence these findings [64]. For example, HDL particles, which contain PL, dif-
fer in humans and rodents in regard to their size patterns [65], which could affect the profiles
of certain PL classes between human and rodents. Therefore, it may be helpful to further study
the lipoprotein composition in rodents in order to understand the complexity of our findings.
Furthermore, it is known that SFA and MUFA can be synthesized de novo within the brain, yet
essential PUFA are mainly supplied from the periphery [61]. Plasma non-esterified-DHA is the
major pool, which supplies the brain with DHA[66]. Additionally, LPC (22:6n3) can be directly
transported from plasma to the brain via the specialized receptors mfsd2a receptor [67]. As
such, increases in essential PUFA containing PL species could indicate transport deficiencies
into various organs, including the brain. However, further investigation of PL content in the
brain is necessary to fully understand the reasons behind those changes.
Additionally, shorter chain PUFA can be used to synthesize their longer chain fatty acid
counterparts, such as AA (20:4n6) and DHA (22:6n3), which are involved in regulating the
intensity and duration of inflammatory responses [68]; possible changes in their levels could
influence the immune/inflammatory imbalances observed in GWI [24]. Our findings in rela-
tion to changes in PUFA, particularly AA and DHA containing PL (e.g. increased DHA con-
taining PC species in humans and rats), suggest that the examination of bioactive metabolites
of AA and DHA in relation to GWI pathology in the future could be useful. Interestingly DHA
and AA containing PC species were also increased in the brains of 5 month old PB+PER GWI
mice [34]. However, further studies investigating lipid enzymes, transport and metabolism
are necessary to understand the relationship between brain and peripheral changes. Yet, this
investigation and previous studies clearly underline the importance of lipid modulation in
GWI pathology [16,19,34,52].
We observed changes in ether containing PL species. As ether PL are dependent upon per-
oxisomes for their synthesis, examination of their functionality should be investigated in the
future. Within all PL classes, only eLPE showed elevation in GWI patients compared to con-
trol. However, in mice no ether lipid class was significantly changed, whereas rats showed sig-
nificant increases for ePC, eLPC and ePE. Again, one possibility could be that the elevated
stress dose in rats leads to changes in ether lipids, which are not observed in humans or mice.
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We compared individual molecular species of each PL class within rats and mice to human
plasma samples to identify species with diagnostic potential and to investigate overlap between
the GWI models and veterans with this condition with the goal of facilitating future transla-
tional work aimed at developing therapies for treating GWI. We observed increases in all clas-
ses for overlapping molecular species. The most consistency was seen for several individual
LPC species, such as LPC(16:0), LPC(18:0), LPC(18:1n9) and LPC(20:4n6).
The rat model showed the strongest signal with elevations reaching up to 200% for all PL
classes. Some epidemiological studies in GW veterans have shown that operational stress
amplifies the effects of GW agents, leading to more severe symptom presentations of GWI
[6,42,43]. These findings have been supported by exercise challenges in humans showing exer-
cise induced hyperalgesia in a GWI subpopulation as well as alterations in immune function-
ing, cognition and brain structure [69]. Moreover animal studies have shown, that combined
GW agent and stress exposure induce long-term behavioral consequences as well as long-term
learning dysfunction in a rat model of GWI [19,20]. Because of this it would be interesting to
include a stress paradigm for veterans and collect plasma samples of GWI veterans after exer-
cise challenge to determine if lipid metabolism is further disturbed.
The most significant changes were observed for LPC and LPE, within the GWI patients
compared to controls. Since these PL can be generated by phospholipase action on PC and PE
[70], additional investigation is needed to explain the observed changes.
Our human sample size was small and therefore we were not able to fully assess the impact
of gender and age on PL levels in this case control study, but instead we adjusted our statistical
analyses to account for these confounding factors. Further validation is required in a larger
cohort to accomplish this. Validation studies using a larger cohort of GWI and control GW
veterans will also allow us the opportunity to assess differential response to various combina-
tions of exposure to GW agents. We further will be able to investigate differences in lipid pro-
files based on the severity of symptoms and different symptom clusters in order to identify
subgroups of veterans with GWI. This could ultimately improve our ability to provide an
objective diagnosis and management of relevant symptoms in subgroups of ill veterans. Use of
i.p. in our mouse model for PB and PER mouse model is also a limitation [71–73] but this
method helps with reducing the variability associated with chemical delivery to mice [71,72].
Furthermore, the observed outcomes are similar to those reported in other rodent models of
GWI at the chronic post-exposure time points, which use oral and the topical routes [44]. As
such, the chronic effects of GW agent exposure appear to be unaffected by the mode of delivery
[44–46,74].
Conclusion
In this study, we identified significantly different overlapping phospholipid changes between
two different rodent models of GWI and a clinical sample of veterans with GWI. These differ-
ences were particularly evident within the lysophospholipids. This first attempt at a pilot trans-
lational study using two different rodent models and a clinical cohort of veterans with GWI
proved successful in suggesting strong potential avenues for further larger studies of phospho-
lipid biomarkers of GWI. These results also provide evidence for further study of these models
for therapeutic target discovery if validated in larger preclinical and clinical samples.
Supporting information
S1 Table. Principal component analysis for human samples showing factors and total vari-
ance associated with each component, which were significantly associated with exposure
based on MLM analyses. In humans, for PC 8 components were identified with PCA analysis,
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of which components 2 (p = 0.005), 4 (p<0.001), 5 (p = 0.006) and 6 (p = 0.032) were signifi-
cant for GWI diagnosis. For LPC 8 components were identified of which component 3 was
significant for GWI (p = 0.003). For PE, component 4 was significant (p = 0.014) out of 8 iden-
tified. For LPE, out of 4 identified components, component 1 was significant (p<0.001) for
GWI. For PI only one component was identified and significant via PCA (p = 0.002). For SM,
3 components were identified with PCA analysis, of which component 1 was significant for
GWI (p = 0.032).
(DOCX)
S2 Table. Principal component analysis for mice samples showing factors and total vari-
ance associated with each component, which were significantly associated with exposure
based on MLM analyses. In mice, for PC 5 components were identified with PCA analysis, of
which component 4 (p = 0.005) was significant for PB+PER exposure. For LPC 4 components
were identified of which component 1 was significant for PB+PER exposure (p<0.001). For
PE, component 1 was significant (p = 0.036) out of 5 identified. For LPE, out of 3 identified
components, component 1 was significant (p = 0.009) for GW agent exposure. For PI 4 com-
ponents were identified and significant via PCA for component 3 (p = 0.008). For SM, 3 com-
ponents were identified with PCA analysis, of which component 3 was significant for PB+PER
(p = 0.044).
(DOCX)
S3 Table. Principal component analysis for rat samples showing factors and total variance
associated with each component, which were significantly associated with exposure based
on MLM analyses. In rats, for PC 3 components were identified with PCA analysis, of which
component 1 (p = 0.017) and 2 (p<0.001) were significant for PB+PER+DEET and stress
exposure. For LPC only 1 component was identified and significant for PB+PER+DEET and
stress exposure (p<0.001). For PE, components 2 (p = 0.003), 4 (p = 0.017), and 5 (p = 0.001)
were significant out of 5 identified. For LPE, out of 3 identified components, component 2 was
significant (p = 0.003) for GW agent and stress exposure. For PI 3 components were identified
and significant via PCA for component 1 (p<0.001). For SM, 1 component was identified with
PCA analysis and significant for PB+PER+DEET and stress exposure (p<0.001).
(DOCX)
S4 Table. Total plasma levels for human samples, mice and rat model of PC, LPC, PE,
LPE, PI and SM quantified by LC/MS analyses (all values are presented in μM ± SEM).
Individual molecular species of each class were quantified by LC/MS and summed after lipido-
meDB analyses to generate total lipid levels. denotes significant p values for p<0.05.
(DOCX)
S5 Table. Plasma levels for humans, mice and rat model of SFA, MUFA and PUFA con-
taining PC, LPC, PE, LPE and PI species quantified by LC/MS analyses (all values are pre-
sented in μM ± SEM). denotes significant p values for p<0.05.
(DOCX)
S6 Table. Plasma levels for humans, mice and rat model of ether containing PC, LPC, PE
and LPE species quantified by LC/MS analyses (all values are presented in μM ± SEM).
denotes significant p values for p<0.05.
(DOCX)
S7 Table. Plasma levels for humans, mice and rat model of AA and DHA containing
PC, LPC, PE and LPE species quantified by LC/MS analyses (all values are presented
in μM ± SEM). No DHA containing LPE species were identified for the rat model, therefore
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ratio for AAtoDHA containing LPE species could not be determined.denotes significant p
values for p<0.05.
(DOCX)
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